Your browser doesn't support javascript.
loading
Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists.
Bewley, Martin A; Budd, Richard C; Ryan, Eilise; Cole, Joby; Collini, Paul; Marshall, Jennifer; Kolsum, Umme; Beech, Gussie; Emes, Richard D; Tcherniaeva, Irina; Berbers, Guy A M; Walmsley, Sarah R; Donaldson, Gavin; Wedzicha, Jadwiga A; Kilty, Iain; Rumsey, William; Sanchez, Yolanda; Brightling, Christopher E; Donnelly, Louise E; Barnes, Peter J; Singh, Dave; Whyte, Moira K B; Dockrell, David H.
Affiliation
  • Bewley MA; 1 Department of Infection, Immunity and Cardiovascular Disease and.
  • Budd RC; 2 The Florey Institute for Host-Pathogen Interactions, University of Sheffield Medical School, Sheffield, United Kingdom.
  • Ryan E; 1 Department of Infection, Immunity and Cardiovascular Disease and.
  • Cole J; 2 The Florey Institute for Host-Pathogen Interactions, University of Sheffield Medical School, Sheffield, United Kingdom.
  • Collini P; 3 Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Marshall J; 4 Department of Respiratory Medicine.
  • Kolsum U; 5 MRC Centre for Inflammation Research, and.
  • Beech G; 1 Department of Infection, Immunity and Cardiovascular Disease and.
  • Emes RD; 2 The Florey Institute for Host-Pathogen Interactions, University of Sheffield Medical School, Sheffield, United Kingdom.
  • Tcherniaeva I; 3 Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Berbers GAM; 1 Department of Infection, Immunity and Cardiovascular Disease and.
  • Walmsley SR; 2 The Florey Institute for Host-Pathogen Interactions, University of Sheffield Medical School, Sheffield, United Kingdom.
  • Donaldson G; 3 Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Wedzicha JA; 5 MRC Centre for Inflammation Research, and.
  • Kilty I; 6 Department of Infection Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Rumsey W; 7 Medicines Evaluation Unit, University of Manchester, Manchester, United Kingdom.
  • Sanchez Y; 8 University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
  • Brightling CE; 7 Medicines Evaluation Unit, University of Manchester, Manchester, United Kingdom.
  • Donnelly LE; 8 University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
  • Barnes PJ; 9 School of Veterinary Medicine and Science and.
  • Singh D; 10 Advanced Data Analysis Centre, University of Nottingham, United Kingdom.
  • Whyte MKB; 11 Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Utrecht, the Netherlands.
  • Dockrell DH; 11 Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Utrecht, the Netherlands.
Am J Respir Crit Care Med ; 198(6): 739-750, 2018 09 15.
Article in En | MEDLINE | ID: mdl-29547002

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phagocytosis / Pulmonary Disease, Chronic Obstructive / NF-E2-Related Factor 2 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2018 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phagocytosis / Pulmonary Disease, Chronic Obstructive / NF-E2-Related Factor 2 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2018 Document type: Article Country of publication: